Reuters Health Report

Click to View in Browser 04/8/2014 Japan drugmaker Takeda to fight $6 billion damages imposed by U.S. jury SAN FRANCISCO/TOKYO (Reuters) - Takeda Pharmaceutical Co Ltd said it would contest $6 billion in punitive damages imposed by a U.S. federal jury in a case alleging Japan's largest drugmaker had concealed cancer risks associated with its Actos diabetes drug. Final Medicare payments to insurers 'less worse': analysts (Reuters) - The Obama administration's announcement on Monday that it would roll back proposed cuts to privately managed Medicare plans is a positive for insurers because the final plan is "less worse" than the one proposed, Wall Street analysts said on Tuesday. Guinea's first Ebola survivors return to family, stigma remains GUECKEDOU, Guinea, April 8 (Thomson Reuters Foundation) - Hiccups, say doctors in this remote corner of Guinea, are the final tell-tale sign of infection by the Ebola virus that has killed more than 100 people since an outbreak began this year. Alkermes' schizophrenia drug meets main goal of late-stage study (Reuters) - Alkermes Plc said its experimental drug to treat the symptoms of schizophrenia met the main goal of reducing the severity of symptoms of the disease in a late-stage study. Scientists regenerate immune organ in mice LONDON (Reuters) - British scientists have for the first time used regenerative medicine to fully restore an organ in a living animal, a discovery they say may pave the way for similar techniques to be used in humans in future. Paralyzed patients regain movement after spinal implant: study NEW YORK (Reuters) - Four men who had each been paralyzed from the chest down for more than two years and been told their situation was hopeless regained the ability to voluntarily move their legs and feet - though not to walk - after an electrical device was implanted in their spines, researchers reported on Tuesday. Obamacare 'accomplishing goal': Gallup poll NEW YORK (Reuters) - The percentage of Americans without health insurance dipped to its lowest in nearly six years due in part to U.S. President Barack Obama's healthcare reform law, commonly known as Obamacare, according to a Gallup poll released on Monday. U.S. childhood obesity rates have increased since 1999: study NEW YORK (Reuters Health) - U.S. childhood obesity rates have increased over the past 14 years, according to a study published on Monday, casting doubt on a recent analysis by government health researchers that found a sharp drop in preschool obesity rates over the past decade. Teva asks Supreme court to stay ruling in Copaxone case WASHINGTON (Reuters) - Teva Pharmaceutical Industries Ltd asked the U.S. Supreme Court on Monday to stop a lower court ruling from going into effect while the justices consider an appeal in a patent fight over Teva's top-selling multiple sclerosis drug Copaxone. Japan drugmaker Takeda to fight $6 billion damages imposed by U.S. jury SAN FRANCISCO/TOKYO (Reuters) - Takeda Pharmaceutical Co Ltd said it would contest $6 billion in punitive damages imposed by a U.S. federal jury in a case alleging that Japan's largest drugmaker had concealed cancer risks associated with its Actos diabetes drug. Related Video Mississippi tornado destroys buildings, injures seven Radiation belt a new line of defence in nuclear emergency The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend